Teligent Pharma, Inc. is recalling 114,456 tubes of Lidocaine Ointment USP, 5%, a prescription topical anesthetic. The recall was initiated because routine testing determined that certain lots did not meet required thickness (viscosity) specifications. If the ointment is too thin, it may result in an inconsistent dosage or difficulty applying the medication properly to the skin. Consumers who have this medication should check their tubes immediately to see if they are part of the affected batches.
The failed viscosity means the product's consistency does not meet quality standards, which can lead to improper drug delivery or reduced effectiveness of the anesthetic. While this poses a low risk of serious injury, it can compromise the treatment's intended numbing effect.
Refund or replacement through healthcare provider/pharmacy
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.